Prostate cancer (PCa) is the most common tumor in men with extremely variable outcome, varying from latent or indolent form to very aggressive behavior. High grade tumors, expansions exceeding the prostatic capsule into the surrounding soft tissues and spreading through lymph vascular channels, represent the most consistent unfavorable prognostic factors. However, accuracy in the prediction of the disease progression is sometimes difficult. Along with new molecular diagnostic techniques and more accurate histopathological approaches, proteomic studies challenge to identify potential biomarkers predictive of PCa progression. In our study we analyzed the urinary proteomes of 42 patients affected by PCa through two-dimensional electrophoresis associated with mass spectrometry. Proteomic profiles were correlated to histopathological features including pTNM stage and tumor differentiation in order to provide new promising markers able to define more accurately the PCa aggressiveness and driving new therapeutic approaches.

Urinary proteomic profiles of prostate cancer with different risk of progression and correlation with histopathological features / Bergamini, S.; Caramaschi, S.; Monari, E.; Martorana, E.; Salviato, T.; Mangogna, A.; Balduit, A.; Tomasi, A.; Canu, P.; Bellei, E.. - In: ANNALS OF DIAGNOSTIC PATHOLOGY. - ISSN 1092-9134. - 51:(2021), pp. 151704-151704. [10.1016/j.anndiagpath.2021.151704]

Urinary proteomic profiles of prostate cancer with different risk of progression and correlation with histopathological features

Bergamini S.;Caramaschi S.;Monari E.;Tomasi A.;Bellei E.
2021

Abstract

Prostate cancer (PCa) is the most common tumor in men with extremely variable outcome, varying from latent or indolent form to very aggressive behavior. High grade tumors, expansions exceeding the prostatic capsule into the surrounding soft tissues and spreading through lymph vascular channels, represent the most consistent unfavorable prognostic factors. However, accuracy in the prediction of the disease progression is sometimes difficult. Along with new molecular diagnostic techniques and more accurate histopathological approaches, proteomic studies challenge to identify potential biomarkers predictive of PCa progression. In our study we analyzed the urinary proteomes of 42 patients affected by PCa through two-dimensional electrophoresis associated with mass spectrometry. Proteomic profiles were correlated to histopathological features including pTNM stage and tumor differentiation in order to provide new promising markers able to define more accurately the PCa aggressiveness and driving new therapeutic approaches.
2021
8-gen-2021
51
151704
151704
Urinary proteomic profiles of prostate cancer with different risk of progression and correlation with histopathological features / Bergamini, S.; Caramaschi, S.; Monari, E.; Martorana, E.; Salviato, T.; Mangogna, A.; Balduit, A.; Tomasi, A.; Canu, P.; Bellei, E.. - In: ANNALS OF DIAGNOSTIC PATHOLOGY. - ISSN 1092-9134. - 51:(2021), pp. 151704-151704. [10.1016/j.anndiagpath.2021.151704]
Bergamini, S.; Caramaschi, S.; Monari, E.; Martorana, E.; Salviato, T.; Mangogna, A.; Balduit, A.; Tomasi, A.; Canu, P.; Bellei, E.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1231216
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 2
social impact